Interações medicamentosas
Nivolumab + Rozanolixizumab
Gravidade: Moderada
Nivolumab and Rozanolixizumab: moderate interaction.
Última atualização
Para profissionais de saúde — apenas referência. Esta página é um resumo breve, não é aconselhamento médico nem substitui a bula oficial ou o julgamento clínico. Verifique sempre antes de prescrever ou dispensar.
O conteúdo clínico desta página está disponível apenas em inglês.
Resumo
Rozanolixizumab blocks the neonatal Fc receptor, which normally protects IgG antibodies from degradation. Nivolumab is an IgG4 antibody, so its clearance could increase and exposure fall, potentially weakening antitumor effect. The clinical significance is uncertain.
O que esta interação significa em palavras simples
Nivolumab and Rozanolixizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Nivolumab belongs to Oncology; Rozanolixizumab belongs to Miscellaneous.
Por que acontece
Rozanolixizumab blocks FcRn-mediated IgG recycling, which may accelerate catabolism of IgG-based nivolumab.
O que fazer
Avoid combining where possible, or monitor tumor response closely if rozanolixizumab is necessary. Involve oncology and neurology specialists in weighing alternatives.
O que perguntar ao farmacêutico
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Para assinantes do Pro+
Desbloqueie a página completa
Crie uma conta e comece um teste do Pro+ para desbloquear a orientação completa de conduta para Nivolumab e Rozanolixizumab, as notas adicionais, os detalhes da evidência e o verificador de interações para uma prescrição completa.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Experimente o Pro+ grátis por 7 dias na web. Sem cartão.
Outras interações de Nivolumab
- Nivolumab + Thalidomide Grave
- Dexamethasone-tobramycin + Nivolumab Moderada
- Dexamethasone + Nivolumab Moderada
- Efgartigimod / hyaluronidase sc + Nivolumab Moderada
- Efgartigimod alfa + Nivolumab Moderada
- Nivolumab + Ponesimod Moderada
Outras interações de Rozanolixizumab
- Rozanolixizumab + Upadacitinib Grave
- Abatacept + Rozanolixizumab Moderada
- Adalimumab + Rozanolixizumab Moderada
- Ado-trastuzumab + Rozanolixizumab Moderada
- Basiliximab + Rozanolixizumab Moderada
- Bevacizumab + Rozanolixizumab Moderada
Perguntas frequentes
Can I take Nivolumab with Rozanolixizumab?
MediHelp rates the interaction as moderate. Nivolumab and Rozanolixizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Rozanolixizumab blocks the neonatal Fc receptor, which normally protects IgG antibodies from degradation. Nivolumab is an IgG4 antibody, so its clearance could increase and exposure fall, potentially weakening antitumor effect. The clinical significance is uncertain.
How serious is the interaction between Nivolumab and Rozanolixizumab?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid combining where possible, or monitor tumor response closely if rozanolixizumab is necessary. Involve oncology and neurology specialists in weighing alternatives.
What other medicines interact with Nivolumab?
MediHelp also lists interactions of Nivolumab with, for example, Thalidomide, Dexamethasone-tobramycin, Dexamethasone. The full list is on the Nivolumab page.
Monografias completas, posologia e verificador de interações no app MediHelp
Abra a referência completa, verifique interações entre vários medicamentos e use as ferramentas de posologia no app MediHelp.
